Tesamorelin

Description

FOR LABORATORY RESEARCH USE ONLY.

Scientific Background

Tesamorelin is a stabilized synthetic peptide analogue of the hypothalamic peptide, Growth Hormone Releasing Hormone (GHRH) indicated for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Lipodystrophy is a metabolic condition characterized by insulin resistance, fat redistribution, and hyperlipidemia associated with antiretroviral therapy for HIV infection

Specification

• Peptide Name: Tesamorelin
• Form: Lyophilized powder
• Purity: ≥ 99 %

Storage & Handling

• Prior to reconstitution: store ≤ 8 °C in a dry environment
• After reconstitution: refrigerate 2 – 8 °C and use within 30 days
• Long-term preservation: aliquot and freeze at −20 °C
• Avoid repeated freeze–thaw cycles

Compliance Notice

This product is supplied strictly for laboratory research purposes and is intended solely for use by qualified researchers and professionals in controlled scientific settings. It is not approved for human or veterinary use, and no dosage, administration, or clinical guidance is provided or implied. The purchaser and end user assume full responsibility for proper handling, storage, regulatory compliance, and adherence to all applicable local and international laws governing research materials